• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    52.32 Up 0.19(0.36%) Dec 19, 4:00PM EST
    |After Hours : 52.32 Up 0.00 (0.01%) Dec 19, 5:35PM EST
    Add to Portfolio
    Prev Close:52.13
    Open:52.04
    Bid:N/A
    Ask:57.00 x 100
    1y Target Est:84.80
    Beta:1.83
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:51.91 - 53.11
    52wk Range:41.99 - 80.42
    Volume:750,988
    Avg Vol (3m):368,359
    Market Cap:1.05B
    P/E (ttm):158.55
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 0.36%1.05B
    LLYDown 0.07%77.44B
    MRKUp 1.02%169.86B
    RHHBYDown 6.59%234.22B

    Key Statistics

    Forward P/E (1 yr):22.75
    P/S (ttm):18.55
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-14) :1.53
    Quarterly EPS Est (Dec-14) :0.60
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback